Genmab A/S
PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTIBODIES DIRECTED AGAINST CD3 AND CD20 AND THEIR USES
Last updated:
Abstract:
The present invention relates to pharmaceutical compositions and dosage unit forms of bispecific CD3xCD20 antibodies and to routes of administration.
Status:
Application
Type:
Utility
Filling date:
8 Feb 2019
Issue date:
4 Feb 2021